blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2250168

EP2250168 - ANGIOTENSIN II RECEPTOR ANTAGONISTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.09.2015
Database last updated on 21.01.2025
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[2014/47]
Former [2012/33]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway NJ 07065-0907 / US
Former [2010/46]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
Inventor(s)01 / ALI, Amjad
126 East Lincoln Avenue
Rahway New Jersey 07065-0907 / US
02 / LO, Michael Man-chu
126 East Lincoln Avenue
Rahway New Jersey 07065-0907 / US
 [2010/46]
Representative(s)Hussain, Deeba, et al
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2014/47]Hussain, Deeba, et al
Merck & Co., Inc.
Patent Department
Hertford Road
Hoddesdon
Hertfordshire EN11 9BU / GB
Former [2010/46]Hussain, Deeba, et al
Merck & Co., Inc. Hertford Road Hoddesdon
Hertfordshire EN11 9BU / GB
Application number, filing date09708827.229.01.2009
[2010/46]
WO2009US32323
Priority number, dateUS20080065082P08.02.2008         Original published format: US 65082 P
[2010/46]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009099853
Date:13.08.2009
Language:EN
[2009/33]
Type: A2 Application without search report 
No.:EP2250168
Date:17.11.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 13.08.2009 takes the place of the publication of the European patent application.
[2010/46]
Type: B1 Patent specification 
No.:EP2250168
Date:19.11.2014
Language:EN
[2014/47]
Search report(s)International search report - published on:US30.12.2009
(Supplementary) European search report - dispatched on:EP24.05.2011
ClassificationIPC:C07D403/14, A61K31/395, A61K31/4184
[2014/28]
CPC:
C07D403/14 (EP,US); A61P11/00 (EP); A61P13/02 (EP);
A61P15/10 (EP); A61P17/00 (EP); A61P25/22 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P27/06 (EP);
A61P3/10 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/10 (EP); A61P9/12 (EP);
C07D401/14 (EP,US) (-)
Former IPC [2010/46]C07D417/14
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/46]
TitleGerman:ANGIOTENSIN-II-REZEPTORANTAGONISTEN[2010/46]
English:ANGIOTENSIN II RECEPTOR ANTAGONISTS[2010/46]
French:ANTAGONISTES DES RÉCEPTEURS DE L'ANGIOTENSINE II[2010/46]
Entry into regional phase08.09.2010National basic fee paid 
08.09.2010Search fee paid 
08.09.2010Designation fee(s) paid 
08.09.2010Examination fee paid 
Examination procedure08.09.2010Examination requested  [2010/46]
20.12.2011Amendment by applicant (claims and/or description)
07.08.2012Despatch of a communication from the examining division (Time limit: M06)
18.02.2013Reply to a communication from the examining division
15.11.2013Despatch of a communication from the examining division (Time limit: M06)
23.05.2014Reply to a communication from the examining division
26.06.2014Communication of intention to grant the patent
13.10.2014Fee for grant paid
13.10.2014Fee for publishing/printing paid
13.10.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.08.2012
Opposition(s)20.08.2015No opposition filed within time limit [2015/44]
Fees paidRenewal fee
06.01.2011Renewal fee patent year 03
09.01.2012Renewal fee patent year 04
08.01.2013Renewal fee patent year 05
08.01.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.01.2009
AT19.11.2014
BG19.11.2014
CY19.11.2014
CZ19.11.2014
DK19.11.2014
EE19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
IT19.11.2014
LT19.11.2014
LV19.11.2014
MC19.11.2014
MK19.11.2014
MT19.11.2014
NL19.11.2014
PL19.11.2014
RO19.11.2014
SE19.11.2014
SI19.11.2014
SK19.11.2014
TR19.11.2014
IE29.01.2015
LU29.01.2015
BE31.01.2015
CH31.01.2015
LI31.01.2015
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
[2018/30]
Former [2017/39]HU29.01.2009
AT19.11.2014
BG19.11.2014
CY19.11.2014
CZ19.11.2014
DK19.11.2014
EE19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
IT19.11.2014
LT19.11.2014
LV19.11.2014
MC19.11.2014
MT19.11.2014
NL19.11.2014
PL19.11.2014
RO19.11.2014
SE19.11.2014
SI19.11.2014
SK19.11.2014
TR19.11.2014
IE29.01.2015
LU29.01.2015
BE31.01.2015
CH31.01.2015
LI31.01.2015
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2017/03]AT19.11.2014
CY19.11.2014
CZ19.11.2014
DK19.11.2014
EE19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
IT19.11.2014
LT19.11.2014
LV19.11.2014
MC19.11.2014
MT19.11.2014
NL19.11.2014
PL19.11.2014
RO19.11.2014
SE19.11.2014
SI19.11.2014
SK19.11.2014
IE29.01.2015
LU29.01.2015
CH31.01.2015
LI31.01.2015
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2016/12]AT19.11.2014
CY19.11.2014
CZ19.11.2014
DK19.11.2014
EE19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
IT19.11.2014
LT19.11.2014
LV19.11.2014
MC19.11.2014
NL19.11.2014
PL19.11.2014
RO19.11.2014
SE19.11.2014
SI19.11.2014
SK19.11.2014
IE29.01.2015
LU29.01.2015
CH31.01.2015
LI31.01.2015
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2016/07]AT19.11.2014
CY19.11.2014
CZ19.11.2014
DK19.11.2014
EE19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
IT19.11.2014
LT19.11.2014
LV19.11.2014
MC19.11.2014
NL19.11.2014
PL19.11.2014
RO19.11.2014
SE19.11.2014
SK19.11.2014
IE29.01.2015
LU29.01.2015
CH31.01.2015
LI31.01.2015
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2016/03]AT19.11.2014
CY19.11.2014
CZ19.11.2014
DK19.11.2014
EE19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
IT19.11.2014
LT19.11.2014
LV19.11.2014
MC19.11.2014
NL19.11.2014
PL19.11.2014
RO19.11.2014
SE19.11.2014
SK19.11.2014
LU29.01.2015
CH31.01.2015
LI31.01.2015
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2015/47]AT19.11.2014
CY19.11.2014
CZ19.11.2014
DK19.11.2014
EE19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
LT19.11.2014
LV19.11.2014
MC19.11.2014
NL19.11.2014
PL19.11.2014
RO19.11.2014
SE19.11.2014
SK19.11.2014
LU29.01.2015
CH31.01.2015
LI31.01.2015
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2015/43]AT19.11.2014
CY19.11.2014
CZ19.11.2014
DK19.11.2014
EE19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
LT19.11.2014
LV19.11.2014
MC19.11.2014
NL19.11.2014
PL19.11.2014
RO19.11.2014
SE19.11.2014
SK19.11.2014
LU29.01.2015
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2015/39]AT19.11.2014
CY19.11.2014
CZ19.11.2014
DK19.11.2014
EE19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
LT19.11.2014
LV19.11.2014
NL19.11.2014
PL19.11.2014
RO19.11.2014
SE19.11.2014
SK19.11.2014
LU29.01.2015
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2015/37]AT19.11.2014
CY19.11.2014
CZ19.11.2014
DK19.11.2014
EE19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
LT19.11.2014
LV19.11.2014
NL19.11.2014
PL19.11.2014
RO19.11.2014
SE19.11.2014
SK19.11.2014
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2015/36]AT19.11.2014
CY19.11.2014
CZ19.11.2014
DK19.11.2014
EE19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
LT19.11.2014
LV19.11.2014
NL19.11.2014
PL19.11.2014
RO19.11.2014
SE19.11.2014
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2015/35]AT19.11.2014
CY19.11.2014
DK19.11.2014
EE19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
LT19.11.2014
LV19.11.2014
NL19.11.2014
PL19.11.2014
SE19.11.2014
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2015/26]AT19.11.2014
CY19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
LT19.11.2014
LV19.11.2014
NL19.11.2014
PL19.11.2014
SE19.11.2014
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2015/25]AT19.11.2014
ES19.11.2014
FI19.11.2014
HR19.11.2014
LT19.11.2014
LV19.11.2014
NL19.11.2014
PL19.11.2014
SE19.11.2014
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2015/24]ES19.11.2014
FI19.11.2014
HR19.11.2014
LT19.11.2014
LV19.11.2014
NL19.11.2014
PL19.11.2014
SE19.11.2014
NO19.02.2015
GR20.02.2015
IS19.03.2015
PT19.03.2015
Former [2015/23]ES19.11.2014
FI19.11.2014
LT19.11.2014
NL19.11.2014
NO19.02.2015
IS19.03.2015
PT19.03.2015
Former [2015/22]LT19.11.2014
NO19.02.2015
PT19.03.2015
Former [2015/21]LT19.11.2014
NO19.02.2015
Former [2015/20]LT19.11.2014
Documents cited:Search[A]WO2005011646  (NICOX SA [FR], et al) [A] 1-10 * page 2, line 15 - line 19 ** claims 1,3,7 *
International search[A]WO2006000294  (MERCK PATENT GMBH [DE], et al);
 [A]US2007032533  (GARVEY DAVID S [US], et al);
 [X]WO2007144512  (SERVIER LAB [FR], et al)
by applicantUS5136069
 US5138069
 US5153197
 WO2005011646
 WO2007144512
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.